Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
SHLTN.SW Stock Summary
Top 10 Correlated ETFs
SHLTN.SW
In the News
SHLTN.SW Financial details
Company Rating
Buy
Market Cap
210.73M
Income
927K
Revenue
40.14M
Book val./share
5.89
Cash/share
1.22
Dividend
-
Dividend %
-
Employees
448
Optionable
No
Shortable
Yes
Earnings
20 Apr 2021
P/E
151.46
Forward P/E
-
PEG
6.62
P/S
3.5
P/B
2.7
P/C
11.31
P/FCF
1088.37
Quick Ratio
1.55
Current Ratio
2.39
Debt / Equity
0.19
LT Debt / Equity
0.45
-
-
EPS (TTM)
0.09
EPS next Y
-
EPS next Q
-
EPS this Y
-608.19%
EPS next Y
-
EPS next 5Y
9534.24%
EPS last 5Y
NAN%
Revenue last 5Y
5.81%
Revenue Q/Q
21.57%
EPS Q/Q
-185.71%
-
-
-
-
SMA20
-8.61%
SMA50
-17.14%
SMA100
-16.89%
Inst Own
-
Inst Trans
-
ROA
1%
ROE
2%
ROC
0.02%
Gross Margin
54%
Oper. Margin
5%
Profit Margin
2%
Payout
-
Shs Outstand
14.52M
Shs Float
11.11M
-
-
-
-
Target Price
-
52W Range
13.1-19.15
52W High
-27.37%
52W Low
+6.15%
RSI
44.6
Rel Volume
0.33
Avg Volume
2.57K
Volume
850
Perf Week
5.34%
Perf Month
-1.43%
Perf Quarter
-20.69%
Perf Half Y
-20.92%
-
-
-
-
Beta
0.716078
-
-
Volatility
0.17%, 0.56%
Prev Close
2.22%
Price
13.8
Change
0.73%
SHLTN.SW Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
Metric | History | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 3.56 | 4.65 | 3.99 | 3.82 | 0.47 | |
Net income per share | 0.23 | 0.97 | 0.54 | 0.03 | -0.13 | |
Operating cash flow per share | 1.13 | 1.21 | 1.03 | 0.45 | 0 | |
Free cash flow per share | 0.98 | 1.1 | 0.85 | 0.28 | -0.03 | |
Cash per share | 0.99 | 0.84 | 0.58 | 1.01 | 0.31 | |
Book value per share | 2.78 | 3.59 | 3.31 | 3.61 | 0.54 | |
Tangible book value per share | 0.27 | 1.42 | 1.16 | 1.43 | 0.02 | |
Share holders equity per share | 2.78 | 3.59 | 3.31 | 3.61 | 0.54 | |
Interest debt per share | 1.48 | 0.12 | 0.03 | 0.26 | 0.41 | |
Market cap | 80.78M | 63.02M | 67.22M | 112.38M | 1.81B | |
Enterprise value | 89.5M | 59.52M | 61.14M | 110.57M | 1.83B | |
P/E ratio | 33.55 | 6.21 | 11.8 | 404.25 | -128.61 | |
Price to sales ratio | 2.16 | 1.29 | 1.6 | 2.8 | 36.6 | |
POCF ratio | 6.82 | 4.94 | 6.2 | 24 | 9.81K | |
PFCF ratio | 7.89 | 5.48 | 7.57 | 38.62 | -590.55 | |
P/B Ratio | 2.77 | 1.67 | 1.93 | 2.97 | 31.92 | |
PTB ratio | 2.77 | 1.67 | 1.93 | 2.97 | 31.92 | |
EV to sales | 2.39 | 1.22 | 1.46 | 2.75 | 36.96 | |
Enterprise value over EBITDA | 10.35 | 3.77 | 6.81 | 20.44 | 769.27 | |
EV to operating cash flow | 7.56 | 4.67 | 5.64 | 23.62 | 9.9K | |
EV to free cash flow | 8.74 | 5.17 | 6.89 | 38 | -596.29 | |
Earnings yield | 0.03 | 0.16 | 0.08 | 0 | -0.01 | |
Free cash flow yield | 0.13 | 0.18 | 0.13 | 0.03 | 0 | |
Debt to equity | 0.05 | 0 | 0 | 0 | 0.5 | |
Debt to assets | 0.55 | 0.32 | 0.42 | 0.42 | 0.53 | |
Net debt to EBITDA | 1.01 | -0.22 | -0.68 | -0.33 | 7.41 | |
Current ratio | 0.84 | 1.43 | 1.11 | 1.24 | 2.64 | |
Interest coverage | 1.15 | 36.1 | 19.57 | 2.33 | -0.05 | |
Income quality | 4.92 | 1.26 | 1.91 | 16.84 | -0.01 | |
Dividend Yield | 0 | 0 | 0.16 | 0 | 0 | |
Payout ratio | 0 | 0 | 1.84 | 0 | 0 | |
Sales general and administrative to revenue | 0.07 | 0.05 | 0.07 | 0.1 | 0.08 | |
Research and developement to revenue | -0.03 | 0 | 0.06 | -0.01 | -0.01 | |
Intangibles to total assets | 0.4 | 0.41 | 0.38 | 0.35 | 0.45 | |
Capex to operating cash flow | -0.14 | -0.1 | -0.18 | -0.38 | -17.61 | |
Capex to revenue | -0.04 | -0.03 | -0.05 | -0.04 | -0.07 | |
Capex to depreciation | -0.35 | -0.31 | -0.5 | -0.36 | -0.61 | |
Stock based compensation to revenue | 0 | 0.01 | 0.01 | 0 | 0.03 | |
Graham number | 3.79 | 8.83 | 6.35 | 1.47 | 1.28 | |
ROIC | 0.04 | 0.3 | 0.12 | 0.02 | 0 | |
Return on tangible assets | 0.06 | 0.31 | 0.15 | 0.01 | -0.2 | |
Graham Net | -2.36 | -0.79 | -1.75 | -1.49 | -0.33 | |
Working capital | -5.12M | 6.95M | 1.34M | 3.44M | 28.5M | |
Tangible asset value | 2.87M | 14.92M | 12.22M | 15.04M | 2.47M | |
Net current asset value | -8.49M | 5.41M | -11.44M | -9M | -22.97M | |
Invested capital | 0.49 | 0.02 | 0 | 0.06 | 0.57 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 1.29M | 1.35M | 1.37M | 1.63M | 2.26M | |
Average inventory | 1.79M | 1.34M | 1.25M | 1.37M | 2.79M | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 19.66 | 21.1 | 22.23 | 30.4 | 42.14 | |
Days of inventory on hand | 45.31 | 25.5 | 22.51 | 25.65 | 61.38 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 18.56 | 17.3 | 16.42 | 12 | 8.66 | |
Inventory turnover | 8.05 | 14.31 | 16.22 | 14.23 | 5.95 | |
ROE | 0.08 | 0.27 | 0.16 | 0.01 | -0.25 | |
Capex per share | -0.15 | -0.12 | -0.19 | -0.17 | -0.03 |
Quarterly Fundamentals Overview
Last date of statement is 2015-06-30 for Q2
Metric | History | 2014-06-30 | 2014-09-30 | 2014-12-31 | 2015-03-31 | 2015-06-30 |
---|---|---|---|---|---|---|
Revenue per share | 1.3 | 0.78 | 0.87 | 0.93 | 1.11 | |
Net income per share | 0.01 | 0.02 | 0.05 | 0.14 | -0.12 | |
Operating cash flow per share | -0.11 | 0.01 | 0.01 | -0.06 | 0.48 | |
Free cash flow per share | -0.22 | -0.1 | -0.12 | -0.13 | 0.38 | |
Cash per share | 2.59 | 1.51 | 1.7 | 0.9 | 1.22 | |
Book value per share | 8.71 | 4.95 | 5.9 | 5.81 | 5.89 | |
Tangible book value per share | 4.56 | 4.95 | 3.14 | 2.5 | 2.58 | |
Share holders equity per share | 8.71 | 4.95 | 5.9 | 5.81 | 5.89 | |
Interest debt per share | 3.48 | 1.89 | 2.22 | 2.14 | 2.21 | |
Market cap | 66.36M | 103.2M | 93.6M | 84.15M | 101.92M | |
Enterprise value | 85.35M | 123.27M | 113.42M | 101.1M | 116.02M | |
P/E ratio | 210 | 100 | 47.85 | 14.73 | -20.42 | |
Price to sales ratio | 6.46 | 10.31 | 10.34 | 8.84 | 8.81 | |
POCF ratio | -74.98 | 1.27K | 1.56K | -135.95 | 20.24 | |
PFCF ratio | -38.03 | -84.11 | -73.7 | -64.24 | 25.89 | |
P/B Ratio | 0.96 | 1.62 | 1.52 | 1.42 | 1.66 | |
PTB ratio | 0.96 | 1.62 | 1.52 | 1.42 | 1.66 | |
EV to sales | 8.31 | 12.31 | 12.54 | 10.62 | 10.03 | |
Enterprise value over EBITDA | 40.16 | 126.56 | 215.23 | 51.32 | 86.65 | |
EV to operating cash flow | -96.44 | 1.52K | 1.89K | -163.33 | 23.04 | |
EV to free cash flow | -48.91 | -100.46 | -89.31 | -77.18 | 29.48 | |
Earnings yield | 0 | 0 | 0.01 | 0.02 | -0.01 | |
Free cash flow yield | -0.03 | -0.01 | -0.01 | -0.02 | 0.04 | |
Debt to equity | 0.24 | 0.23 | 0.21 | 0.2 | 0.19 | |
Debt to assets | 0.35 | 0.34 | 0.33 | 0.35 | 0.36 | |
Net debt to EBITDA | 8.93 | 20.6 | 37.62 | 8.61 | 10.53 | |
Current ratio | 2.46 | 2.59 | 2.45 | 1.86 | 1.82 | |
Interest coverage | 0.19 | 0.43 | -7.84 | 10.56 | -0.56 | |
Income quality | -11.2 | 0.31 | 0.12 | -0.43 | -4.04 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.2 | 0.19 | -0.36 | 0.07 | 0.24 | |
Research and developement to revenue | 0.06 | 0.06 | -0.35 | 0.06 | 0.04 | |
Intangibles to total assets | 0.31 | 0 | 0.31 | 0.37 | 0.36 | |
Capex to operating cash flow | 0.97 | -16.15 | -22.17 | 1.12 | -0.22 | |
Capex to revenue | -0.08 | -0.13 | -0.15 | -0.07 | -0.1 | |
Capex to depreciation | -0.61 | 0 | 0 | 0 | -0.66 | |
Stock based compensation to revenue | 0.01 | 0 | 0 | 0 | 0.01 | |
Graham number | 1.4 | 1.49 | 2.5 | 4.28 | 3.99 | |
ROIC | 0 | 0 | 0.01 | 0.02 | -0.01 | |
Return on tangible assets | 0 | 0 | 0.01 | 0.02 | -0.02 | |
Graham Net | -2.05 | -0.93 | -1.14 | -2.14 | -1.91 | |
Working capital | 27.51M | 25.57M | 23.77M | 15.46M | 16.13M | |
Tangible asset value | 36.02M | 0 | 32.68M | 25.49M | 26.87M | |
Net current asset value | 8.92M | 9.14M | 9.41M | 1.36M | 1.9M | |
Invested capital | 0.39 | 0.38 | 0.38 | 0.36 | 0.36 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 2.43M | 2.02M | 1.93M | 1.81M | 2.1M | |
Average inventory | 2.92M | 3.06M | 3.34M | 3.23M | 3.53M | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 39.3 | 23.64 | 21.54 | 17.05 | 19.95 | |
Days of inventory on hand | 32.5 | 38.99 | 54.41 | 52.05 | 43.28 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 2.29 | 3.81 | 4.18 | 5.28 | 4.51 | |
Inventory turnover | 2.77 | 2.31 | 1.65 | 1.73 | 2.08 | |
ROE | 0 | 0 | 0.01 | 0.02 | -0.02 | |
Capex per share | -0.11 | -0.1 | -0.13 | -0.07 | -0.11 |
SHLTN.SW Frequently Asked Questions
What is SHL Telemedicine Ltd. stock symbol ?
SHL Telemedicine Ltd. is a IL stock and trading under the symbol SHLTN.SW
What is SHL Telemedicine Ltd. stock quote today ?
SHL Telemedicine Ltd. stock price is $13.8 today.
Is SHL Telemedicine Ltd. stock public?
Yes, SHL Telemedicine Ltd. is a publicly traded company.